News

Manulife Investment Management Strengthens Global Equity Leadership

Manulife Investment Management Strengthens Global Equity Leadership

Manulife Investment Management Strengthens Global Equity Leadership

Manulife Investment Management is embarking on an exciting new chapter by enhancing its equity organization. In a strategic move, the firm is bringing together its expertise across regions to improve the investment experience for its clients. The appointment of Charlie Dutton as the Chief Investment Officer for Global Emerging Market Equities marks a significant milestone in this endeavor. Dutton, an accomplished equity investment leader, will oversee and align the firm's Asia ex-Japan and emerging market equity capabilities, ensuring that local resources and insights are fully leveraged.

Experience and Commitment to Emerging Markets

With a legacy spanning more than a century in emerging markets, Manulife Investment Management boasts one of the largest equity teams based in Asia. This team consists of over 90 dedicated investment professionals operating across ten diverse markets in the region. The firm aims to combine local insights with its profound investment expertise to create an information advantage that few other asset managers outside Asia can match. The newly formed Emerging Market Equities organization is responsible for managing over US$25 billion in assets under management (AUM) across various equity strategies in Asia and emerging markets.

Improving Collaboration and Engagement

At the heart of Manulife's investment culture is collaboration and engagement. The alignment of the Asia equity team with the global Emerging Markets equity group formalizes a long-standing tradition of sharing insights and ideas. According to Colin Purdie, Global Chief Investment Officer for Public Markets, this formal integration is expected to enhance research sharing and investment decision-making, allowing for custom-tailored solutions to better serve client needs.

Charlie Dutton’s Vision as CIO

In his new role, Charlie Dutton will spend considerable time in Asia, engaging with extensive investment teams spread across the region. Based in London, he will maintain effective communication with investment professionals in both London and Asia, fostering connections that enhance the organization’s collaborative efforts.

A Seasoned Leader with Vast Experience

Bringing over 27 years of investment experience to his new role, Dutton has a wealth of expertise in Asia equity investments. His career has included over 25 years dedicated to this field, with notable time spent in Hong Kong, South Africa, and London. Before joining Manulife Investment Management, Charlie was a fund manager with Ninety One, part of a team responsible for managing assets across five strategies.

Previous Successes and Achievements

Prior to his tenure at Ninety One, Dutton was a founding partner at Coupland Cardiff, focusing on Asian equity funds for a decade. His early career included positions as director of Asia-Pacific research at JPMorgan and as a consumer analyst at JF Securities in Hong Kong. Dutton began his journey at HSBC, initially working in Hong Kong as an analyst specializing in Hong Kong and China.

Strategic Changes Within the Organization

Amid these developments, Manulife Investment Management also announced that Kathryn Langridge, Senior Managing Director and Head of the Emerging Markets Equity team, plans to retire after a remarkable investment career spanning over 40 years. Additionally, Ronald Chan, CIO for Asia ex-Japan Equity, is also departing the organization.

Moving Forward with Strength

Charlie Dutton remarks on the significance of aligning the Asia and Emerging Markets equity teams, emphasizing the critical role that Asia plays in the current equity markets. This alignment is not only a testament to the deep pool of talent within Manulife's investment organization but also positions the firm to effectively deliver for clients, expanding the research and insights available through the Emerging Markets equity team.

About Manulife Wealth & Asset Management

Part of Manulife Financial Corporation, Manulife Wealth & Asset Management serves a global clientele, providing investment, financial advice, and retirement plan services to millions across the globe. The firm is committed to making financial decisions easier and enriching lives by helping clients invest confidently for a better tomorrow. With a strong heritage in risk management and deep expertise in both public and private markets, Manulife aims to enhance investment outcomes and help individuals build a secure financial future.

Frequently Asked Questions

What is the role of Charlie Dutton at Manulife Investment Management?

Charlie Dutton has been appointed as the Chief Investment Officer for Global Emerging Market Equities, overseeing the integration of Asia and emerging market equity strategies.

How much does Manulife manage in emerging markets?

Manulife Investment Management manages over US$25 billion in assets under management across Asia and emerging markets equity strategies.

What is the significance of aligning Asia and Emerging Markets teams?

The alignment aims to enhance collaboration, improve research sharing, and decision-making processes, ultimately providing better tailored solutions for clients.

What experience does Charlie Dutton bring to his new position?

Charlie Dutton brings over 27 years of investment experience, with a strong focus on Asia equity investment over the past 25 years.

What changes are being made at the leadership level?

Kathryn Langridge is set to retire after more than 40 years, and Ronald Chan is also leaving Manulife Investment Management, paving the way for new leadership under Charlie Dutton.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

WeightWatchers Shifts 2025 Earnings Call for Key Accounting Updates

Updated Category News Views 154

WeightWatchers Adjusts Schedule for 2025 Earnings Report WW International, Inc. (NASDAQ: WW), widely recognized for its innovative weight management solutions, has made an important change regarding its upcoming earnings report. The company has rescheduled its earnings release and associated conference call originally intended for August 5, 2025. This Rescheduling is...

Continue Reading
Investors Alert: Key Investigations into Regeneron Pharmaceuticals

Updated Category News Views 120

Investors Take Note: Faruqi & Faruqi Seeks to Help Faruqi & Faruqi, LLP, a prominent national securities litigation firm, is leading an investigation focusing on investors who may have sustained significant losses with Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). The firm encourages those who believe they have suffered losses of over $100,000 due to the company’s...

Continue Reading
Waller's Bold Critique of Powell: A Call for Rate Cuts

Updated Category News Views 233

Waller’s Challenge to Economic Caution Federal Reserve Governor Christopher Waller has made headlines by challenging the stance of Chairman Jerome Powell, particularly regarding his assertion that economic data is too sparse to draw clear conclusions. Waller believes the Fed should proceed with easing monetary policy, even amidst perceived gaps in information. Ending...

Continue Reading
Michael John Politis Recognized as Elite Attorney in America

Updated Category News Views 276

Michael John Politis Achieves National Recognition Michael John Politis, a distinguished attorney at Politis & Matovina, P.A., has garnered significant acclaim by being recognized as a member of the Nation's Top One Percent. This prestigious acknowledgment is bestowed by the National Association of Distinguished Counsel (NADC). The NADC is committed to upholding the...

Continue Reading
Home Buying Opportunities: Navigating the Market's Shift

Updated Category News Views 74

Introduction For many home buyers, fall typically signals a slow down in the housing market. But this year, things might unfold differently. With mortgage rates dropping and inventory on the rise, buyers could have a chance to find their dream homes during what is usually seen as the offseason. Affordability Improves The recent decline in monthly mortgage payments has...

Continue Reading